SREBF1 and cancer: Recently, in addition to the regulatory role of lipid homeostasis, accumulating data have found that abnormal SREBP-1 expression levels might affect the development of cancers, including ovarian, breast, and CRC, and initiate the occurrence of therapeutic resistance [14].